Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
Reversing cachexia
Michael J. Tisdale
*
*
Corresponding author for this work
Aston Pharmacy School
College of Health and Life Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Reversing cachexia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cachexia
100%
ActRIIB
50%
Skeletal muscle
25%
In Cancer
25%
Muscle Atrophy
25%
Cancer Patients
25%
Life-limiting Conditions
25%
Therapeutic Potential
25%
Mouse Model
25%
New Targets
25%
Cardiac muscle
25%
Activin Type II Receptor
25%
Decoy Receptor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cachexia
100%
Receptor
25%
Muscle Atrophy
25%
Malignant Neoplasm
25%
Mouse Model
25%
Activin Receptor 2
25%